Filing Details
- Accession Number:
- 0001203311-21-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-18 20:29:05
- Reporting Period:
- 2021-08-16
- Accepted Time:
- 2021-08-18 20:29:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1361966 | B Vaughn Himes | 21823 30Th Drive Se Bothell WA 98021 | Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-16 | 658 | $154.55 | 52,354 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-08-16 | 8,718 | $0.00 | 61,072 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Acquisiton | 2021-08-16 | 642 | $0.00 | 642 | $155.87 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2021-08-16 | 20,626 | $0.00 | 20,626 | $155.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 642 | 2031-08-16 | No | 4 | A | Direct | |
| 20,626 | 2031-08-16 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 120,605 | Indirect | by Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 50 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 30, 2021.
- These shares represent restricted stock units and will be settled in common stock upon vesting.
- Shares shall vest at a rate of 25% on each anniversary of August 15, 2021 until all shares are fully vested at the end of four years.
- Options shall vest at a rate of 25% one year from grant date and monthly thereafter until all options are fully vested four years from grant date.
Billionaire Hedge Funds
